This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Javelin Pharmaceuticals, EDAP: Early Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading near $5 were moving on above-average volume during Monday's session.

EDAP TMS S.A. (EDAP - Get Report) jumped by 42 cents, or 13.3%, to $3.53 after the medical-device maker said it has received European approval for its new lithotripter, the Sonolith i-move. The device is used for the ultrasound localization of kidney stones. Volume topped 391,000 shares, compared to the 50-day average daily volume of 143,000, according to the Nasdaq.

Netlist (NLST - Get Report) rose by 26 cents, or 7.7%, to $3.62 after the memory-subsystems maker announced the qualification of its HyperCloud memory component on Super Micro Computer high-density servers. Volume topped 460,000 shares in the first 45 minutes of trading Monday, compared to the 50-day average daily volume of 1.01 million.

PremierWest Bancorp (PRWT) gained 6 cents, or 8.4%, to 75 cents after Briefing.com noted market chatter regarding a stock newsletter that suggested PremierWest could be an acquisition target for KeyCorp (KEY - Get Report). Volume topped 2.24 million shares, compared to the 50-day average daily volume of 1.44 million.

Javelin Pharmaceuticals (JAV) rallied by 82 cents, or 61.2%, to $2.16 after the company terminated its merger agreement with Myriad Pharmaceuticals (MYRX) after receiving a higher $141 million takeover offer from Hospira (HSP - Get Report), which valued shares of Javelin at $2.20 per share. Myriad's offer for Javelin was worth $81 million, or $1.27 per share, based on Friday's closing prices. Volume topped 9.91 million shares, compared to the three-month average daily volume of 457,000, according to Yahoo! Finance.

-- Written by Robert Holmes in Boston.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store. View the Dollar Store portfolio on StockPickr.

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
MYRX $0.15 0.00%
EDAP $3.26 0.00%
HSP $88.95 0.00%
KEY $15.08 0.00%
NLST $0.58 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs